Your Messages Inbox
Your Article Summary
See Latest ArticlesAvigen Reports Second Quarter 2009 Financial Results
Avigen, 08/11/09
Avigen, Inc. a biopharmaceutical company, reported financial results for its second quarter ended June 2009. At June 2009, Avigen had approximately $41.6 million in financial assets, including cash, cash equivalents and available–for–sale securities and restricted investments, compared with approximately $56.8 million at December 2008 before repaying $7.0 million of outstanding bank borrowings in March 2009. More complete financial results are detailed in the financial tables below.
Today in Financial Reports...keeping you current
Receive free subspecialty "5-minute updates" via email
Medtronic Board Approves Third Quarter Cash Dividend for Fiscal Year 2010
Medtronic, 12/04/09
Taro Provides Preliminary Third Quarter and Year-to-Date 2009 Financial Results
Taro Pharmaceuticals USA, 12/03/09
IMS Predicts 4% to 6% Global Pharma Market Growth Next Year
U.S. Pharmacist, 12/02/09
Article Search
Sponsor